Chlorpromazine reduces UV-induced squamous cell carcinogenesis in hairless mice and enhances UV-induced DNA damage in cultured cells
1989
Chlorpromazine and UV-Induced Skin Cancer in Mice
Sample size: 100
publication
Evidence: moderate
Author Information
Author(s): M.J. Peak, M. Pfaff, C. Peraino
Primary Institution: Argonne National Laboratory
Hypothesis
Does chlorpromazine reduce UV-induced skin cancer in hairless mice?
Conclusion
Chlorpromazine significantly reduces the rates of squamous cell carcinomas induced by UV radiation in hairless mice.
Supporting Evidence
- Chlorpromazine reduced tumor yields by approximately 80%.
- DNA damage was enhanced in cultured cells exposed to chlorpromazine and UV radiation.
- All visible tumors were diagnosed as squamous cell carcinomas.
Takeaway
Chlorpromazine, a common medication, helps protect mice from skin cancer caused by sunlight.
Methodology
Hairless SKH-1 mice were divided into treatment groups and exposed to UV radiation with or without chlorpromazine in their drinking water.
Limitations
The study was conducted on mice, and results may not directly translate to humans.
Participant Demographics
Male and female hairless SKH-1 mice, aged 5-10 weeks.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website